Published in Cell Regul on December 01, 1991
Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases. J Clin Pathol (1996) 0.84
Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res (1985) 8.64
A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med (1978) 3.92
A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J Cell Biol (1985) 3.62
Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade. Cell (1986) 3.42
Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J (1990) 3.27
Differentiation-enhanced binding of the amino-terminal fragment of human urokinase plasminogen activator to a specific receptor on U937 monocytes. Proc Natl Acad Sci U S A (1985) 2.72
The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J Cell Biol (1986) 2.50
Autocrine saturation of pro-urokinase receptors on human A431 cells. Cell (1986) 2.38
Plasminogen activation initiated by single-chain urokinase-type plasminogen activator. Potentiation by U937 monocytes. J Biol Chem (1989) 2.05
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol (1989) 1.93
Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol (1990) 1.91
In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface-bound urokinase. J Cell Biol (1988) 1.90
Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem (1989) 1.84
Binding and activation of plasminogen on the platelet surface. J Biol Chem (1985) 1.76
Modulation of metastatic potential by cell surface urokinase of murine melanoma cells. Cancer Res (1988) 1.70
Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors. J Biol Chem (1990) 1.52
Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans. Am J Pathol (1991) 1.50
Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1989) 1.29
Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion. J Cell Biol (1989) 1.14
Characterization of a macrophage-derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor. Biochem J (1985) 1.12
Cell lines derived from a human myelomonocytic leukaemia. Br J Haematol (1982) 1.09
Endogenous receptor-bound urokinase mediates tissue invasion of human monocytes. J Immunol (1989) 1.06
Minactivin: a human monocyte product which specifically inactivates urokinase-type plasminogen activators. Eur J Biochem (1983) 0.98
Activation of pro-urokinase by the human T cell-associated serine proteinase HuTSP-1. FEBS Lett (1990) 0.97
Complex-formation and inhibition of urokinase by blood plasma proteins. Biochem J (1983) 0.95
Minactivin expression in human monocyte and macrophage populations. Blood (1985) 0.90
The inhibition of high and low molecular weight urokinase in plasma. Blood (1980) 0.90
Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2. Eur J Biochem (1988) 0.89
Structural and functional characterization of the inhibition of urokinase by alpha 2-macroglobulin. Biochemistry (1985) 0.87
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor. Proc Natl Acad Sci U S A (1990) 0.86
Receptor for plasmin on human carcinoma cells. J Natl Cancer Inst (1988) 0.85
Production of an active urokinase by leukemia cells: a novel distinction from cell lines of solid tumors. Leuk Res (1988) 0.85
Microplate immunocapture assay for plasminogen activators and their specific inhibitors. J Immunol Methods (1987) 0.85
Novel properties of human monocyte plasminogen activator. Eur J Biochem (1984) 0.85
Plasminogen activation by t-PA on the surface of human melanoma cells in the presence of alpha 2-macroglobulin secretion. Cell Regul (1990) 0.85
alpha 2-macroglobulin traps a proteinase in the midregion of its arms. An immunoelectron microscopic study. J Biol Chem (1989) 0.82
Human tumor cells synthesize and secrete alpha-2-macroglobulin in vitro. Int J Cancer (1986) 0.81
Enhanced activation of prourokinase by human RC2A leukemia cells. Semin Thromb Hemost (1991) 0.76
Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor. J Cell Physiol (1989) 0.76
Rubella: a method for rapid diagnosis of a recent infection by demonstration of the IgM antibodies. Br Med J (1968) 5.54
Purification of fibronectin from human plasma by affinity chromatography under non-denaturing conditions. Biochem J (1979) 4.46
Nephropathia epidemica: detection of antigen in bank voles and serologic diagnosis of human infection. J Infect Dis (1980) 4.10
Ezrin contains cytoskeleton and membrane binding domains accounting for its proposed role as a membrane-cytoskeletal linker. J Cell Biol (1993) 3.96
Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med (1978) 3.95
Interaction of soluble fibroblast surface antigen with fribrinogen and fibrin. J Exp Med (1975) 3.91
High molecular weight, cell surface-associated glycoprotein (fibronectin) lost in malignant transformation. Biochim Biophys Acta (1978) 3.89
Ezrin has a COOH-terminal actin-binding site that is conserved in the ezrin protein family. J Cell Biol (1994) 3.68
Cytopathic effect of rubella virus in RHK21 cells and growth to high titers in suspension culture. Virology (1965) 3.50
Disappearance of a major cell-type specific surface glycoprotein antigen (SF) after transformation of fibroblasts by Rous sarcoma virus. Int J Cancer (1974) 3.24
Antigenic and genetic properties of viruses linked to hemorrhagic fever with renal syndrome. Science (1985) 3.17
Factors influencing the enhancement of the infectivity of poliovirus ribonucleic acid by diethylaminoethyl-dextran. J Virol (1967) 2.95
Distribution of fibroblast surface antigen in the developing chick embryo. J Exp Med (1975) 2.85
Induction of a basement membrane glycoprotein in embryonic kidney: possible role of laminin in morphogenesis. Proc Natl Acad Sci U S A (1980) 2.74
Fibroblast surface antigen: a new serum protein. Biochim Biophys Acta (1973) 2.71
External fibronectin of cultured human fibroblasts is predominantly a matrix protein. J Cell Biol (1978) 2.70
Distribution of fibroblast surface antigen: association with fibrillar structures of normal cells and loss upon viral transformation. J Exp Med (1974) 2.62
Cytovillin, a microvillar Mr 75,000 protein. cDNA sequence, prokaryotic expression, and chromosomal localization. J Biol Chem (1989) 2.61
Hantaviruses: genome structure, expression and evolution. J Gen Virol (1996) 2.47
Fibronectin is produced by human macrophages. J Exp Med (1980) 2.44
Novel human serum protein from fibroblast plasma membrane. Nature (1974) 2.35
Rheumatoid factor in acute viral infections: interference with determination of IgM, IgG, and IgA antibodies in an enzyme immunoassay. J Infect Dis (1980) 2.33
Codistribution of pericellular matrix proteins in cultured fibroblasts and loss in transformation: fibronectin and procollagen. Proc Natl Acad Sci U S A (1978) 2.32
Infectious poliovirus RNA: a sensitive method of assay. Virology (1965) 2.28
Appearance and distribution of collagens and laminin in the early mouse embryo. Dev Biol (1980) 2.27
Enhancement of infectivity of poliovirus RNA with diethylaminoethyl-dextran (DEAE-D). Arch Gesamte Virusforsch (1965) 2.25
Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20
Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19
Dimeric character of fibronectin, a major cell surface-associated glycoprotein. Biochem Biophys Res Commun (1977) 2.18
Sequential appearance of fibronectin and collagen in experimental granulation tissue. Lab Invest (1980) 2.16
ICAM-2 redistributed by ezrin as a target for killer cells. Nature (1996) 2.04
Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate. J Biol Chem (1998) 2.01
Ultrastructural localization of plasma membrane-associated urokinase-type plasminogen activator at focal contacts. J Cell Biol (1988) 1.97
Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J Neurovirol (2001) 1.96
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J Cell Biol (1989) 1.93
Epidemiological study of nephropathia epidemica in Finland 1989-96. Scand J Infect Dis (1999) 1.93
Soluble antigen-antibody complexes and platelet aggregation. Acta Pathol Microbiol Scand (1969) 1.91
Biosynthesis of two subunits of type IV procollagen and of other basement membrane proteins by a human tumor cell line. Eur J Biochem (1980) 1.90
Fibroblast surface antigen produced but not retained by virus-transformed human cells. J Exp Med (1975) 1.81
Chlamydia trachomatis seropositivity during pregnancy is associated with perinatal complications. Clin Infect Dis (1995) 1.79
Rapid diagnosis of hantavirus disease with an IgG-avidity assay. Lancet (1991) 1.79
Distinct localizations of urokinase-type plasminogen activator and its type 1 inhibitor under cultured human fibroblasts and sarcoma cells. J Cell Biol (1987) 1.79
Isolation and characterization of Dobrava hantavirus carried by the striped field mouse (Apodemus agrarius) in Estonia. J Gen Virol (1999) 1.77
Case-control study on Puumala virus infection: smoking is a risk factor. Epidemiol Infect (2009) 1.74
Microvillus-specific Mr 75,000 plasma membrane protein of human choriocarcinoma cells. J Histochem Cytochem (1987) 1.71
A common cell-type specific surface antigen in cultured human glial cells and fibroblasts: loss in malignant cells. J Exp Med (1976) 1.70
Cultured human monocytes synthesize and secrete alpha2-macroglobulin. J Exp Med (1977) 1.70
Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem (1981) 1.66
Cerebrospinal fluid alterations in herpes simplex virus encephalitis. Rev Infect Dis (1984) 1.64
Cross-linking of a major fibroblast surface-associated glycoprotein (fibronectin) catalyzed by blood coagulation factor XIII. Cell (1976) 1.64
Hemorrhagic fever with renal syndrome in Finland: ecology and virology of nephropathia epidemica. Scand J Infect Dis Suppl (1982) 1.62
Human B-cell epitopes of Puumala virus nucleocapsid protein, the major antigen in early serological response. J Med Virol (1995) 1.61
Detection and characterization of immune complexes by the platelet aggregation test. I. Complexes formed in vitro. Clin Exp Immunol (1971) 1.60
Laminin is produced by early rat astrocytes in primary culture. J Cell Biol (1983) 1.59
Nephropathia epidemica in Finland: a retrospective study of 126 cases. Scand J Infect Dis (1994) 1.59
Cloning and sequencing of Puumala virus Sotkamo strain S and M RNA segments: evidence for strain variation in hantaviruses and expression of the nucleocapsid protein. J Gen Virol (1992) 1.58
Cytokines, adhesion molecules, and cellular infiltration in nephropathia epidemica kidneys: an immunohistochemical study. Clin Immunol Immunopathol (1996) 1.55
Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J Virol (1999) 1.54
Prognostic factors in childhood acute encephalitis. Pediatr Infect Dis J (1991) 1.53
Isolation and characterization of Tula virus, a distinct serotype in the genus Hantavirus, family Bunyaviridae. J Gen Virol (1996) 1.52
Human spumaretrovirus in the etiology of sudden hearing loss. Acta Otolaryngol (1993) 1.49
Synthesis and secretion of alpha-2-macroglobulin by cultured adherent lung cells. Comparison with cell strains derived from other tissues. J Clin Invest (1977) 1.48
Distribution of fibronectin in human tissues and relationship to other connective tissue components. Ann N Y Acad Sci (1978) 1.47
A five-year perspective on the situation of haemorrhagic fever with renal syndrome and status of the hantavirus reservoirs in Europe, 2005-2010. Euro Surveill (2011) 1.45
Rapid solid-phase enzyme immunoassay for antibodies to viruses and other microbes: effects of polyethylene glycol. J Immunol Methods (1981) 1.44
Isolation of attenuated rubella-vaccine virus from human products of conception and uterine cervix. N Engl J Med (1972) 1.44
Immunological interspecies cross-reactions of fibroblast surface antigen (fibronectin). Immunochemistry (1976) 1.44
Cold-insoluble globulin mediates the adhesion of rat liver cells to plastic Petri dishes. Biochem Biophys Res Commun (1977) 1.43
Familial herpes encephalitis. Lancet (1995) 1.40
Genetic susceptibility to severe course of nephropathia epidemica caused by Puumala hantavirus. Kidney Int (1996) 1.40
Genetic analysis of wild-type Dobrava hantavirus in Slovenia: co-existence of two distinct genetic lineages within the same natural focus. J Gen Virol (2000) 1.40
Thy-1 is a neuronal and glial surface antigen which interacts with matrix proteins and plasminogen activator. Exp Brain Res (1990) 1.38
Detection of herpes simplex virus DNA in cerebrospinal fluid samples using the polymerase chain reaction and microplate hybridization. J Virol Methods (1996) 1.38
Interaction between human blood platelets, viruses and antibodies. IV. Post-Rubella thrombocytopenic purpura and platelet aggregation by Rubella antigen-antibody interaction. Clin Exp Immunol (1969) 1.38
The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res (1998) 1.38
Dissociation of fibronectin from gelatin-agarose by amino compounds. Biochem J (1978) 1.38
Stimulation of density-inhibited cell cultures by insulin. J Cell Physiol (1973) 1.37
Antigenic properties and diagnostic potential of puumala virus nucleocapsid protein expressed in insect cells. J Clin Microbiol (1996) 1.35
Transmission of attenuated rubella vaccines to the human fetus. A preliminary report. Am J Dis Child (1969) 1.34
Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci (1997) 1.33
Pericellular matrix in malignant transformation. Adv Cancer Res (1982) 1.32
Thrombin stimulates the production and release of a major surface-associated glycoprotein (fibronectin) in cultures of human fibroblasts. Exp Cell Res (1978) 1.31
Sequences of wild Puumala virus genes show a correlation of genetic variation with geographic origin of the strains. J Gen Virol (1994) 1.31
Changes in the distribution of type IV collagen, laminin, proteoglycan, and fibronectin during mouse tooth development. Dev Biol (1981) 1.30
Glial fibrillary acidic protein and intermediate filaments in human glioma cells. Acta Neuropathol (1979) 1.29
Changes in expression of fibroblast surface antigen (SFA) during cytodifferentiation and heterokaryon formation. Differentiation (1976) 1.29
Demonstration of fibronectin in human cerebrospinal fluid. J Lab Clin Med (1978) 1.28
Laminin is induced in astrocytes of adult brain by injury. EMBO J (1984) 1.28
Wild-type Puumala hantavirus infection induces cytokines, C-reactive protein, creatinine, and nitric oxide in cynomolgus macaques. J Virol (2002) 1.27
Detection and characterization of immune complexes by the platelet aggregation test. II. Circulating complexes. Clin Exp Immunol (1971) 1.26
Interaction between molecules of hantavirus nucleocapsid protein. J Gen Virol (2001) 1.26
Polypeptides of a glycoprotein antigen (SF) present in serum and surface of normal but not of transformed chicken fibroblasts. Biochim Biophys Acta (1975) 1.25
Structural proteins and subunits of rubella virus. J Virol (1972) 1.25
Fibroblast surface antigen (SF): molecular properties, distribution in vitro and in vivo, and altered expression in transformed cells. J Supramol Struct (1976) 1.23
Ezrin as a prognostic indicator and its relationship to tumor characteristics in uveal malignant melanoma. Invest Ophthalmol Vis Sci (2001) 1.22
Neuraminidase stimulates division and sugar uptake in density-inhibited cell cultures. Nat New Biol (1972) 1.22
Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin. J Cell Sci (1999) 1.22